Can terbutaline be administered to a patient with sinus bradycardia and early repolarization (upward‑sloping ST segment)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can Terbutaline Be Given in Sinus Bradycardia with Early Repolarization?

Yes, terbutaline can be administered to patients with sinus bradycardia, but only if the patient is symptomatic or hemodynamically compromised AND at low risk for coronary ischemia. The early repolarization pattern (upward-sloping ST segment) itself is not a contraindication, but the underlying cardiac risk profile is critical.

Clinical Decision Framework

Step 1: Assess Symptom Severity and Hemodynamic Status

  • If asymptomatic or stable: No acute pharmacologic therapy is needed 1
  • If symptomatic or hemodynamically compromised: Proceed to Step 2

Step 2: Evaluate Coronary Ischemia Risk

This is the critical decision point. The 2018 ACC/AHA/HRS guidelines specifically state that beta-agonists (including isoproterenol, dopamine, dobutamine, or epinephrine) may be considered for symptomatic sinus node dysfunction, but only in patients "at low likelihood of coronary ischemia" (Class IIb recommendation) 1.

Terbutaline carries significant cardiovascular warnings:

  • FDA labeling explicitly warns to use with caution in patients with "cardiovascular disorders, including ischemic heart disease, hypertension, and cardiac arrhythmias" 2
  • Can cause ECG changes including T-wave flattening, QTc prolongation, and ST segment depression 2
  • May produce clinically significant cardiovascular effects including changes in blood pressure and heart rate 2, 3

Step 3: Consider First-Line Alternatives

Atropine is the preferred initial agent (Class IIa recommendation) for symptomatic sinus bradycardia 1. It has a better safety profile and should be tried first at 0.5-1 mg IV, repeated every 3-5 minutes up to 3 mg total.

Step 4: Rule Out Reversible Causes First

Before using any chronotropic agent, evaluate and treat reversible causes 1:

  • Medications (beta-blockers, calcium channel blockers, digoxin, antiarrhythmics)
  • Electrolyte abnormalities (hyperkalemia, hypokalemia)
  • Hypothyroidism
  • Acute myocardial ischemia
  • Hypoxemia, acidosis

Specific Considerations for Terbutaline

When Terbutaline May Be Appropriate:

  • Post-heart transplant patients with sinus node dysfunction represent the best-studied population 4, 5, 6
  • In this denervated heart setting, terbutaline has shown efficacy with relatively low permanent pacemaker rates (6.6-6.7%) 4, 5
  • Typical dosing: 2.5-5 mg orally every 6-8 hours, titrated to effect 6

Critical Contraindications and Cautions:

  • Active coronary ischemia or high ischemic risk: Terbutaline can worsen myocardial oxygen demand
  • Cardiac arrhythmias: May precipitate tachyarrhythmias (occurred in 12.7% of post-transplant patients) 5
  • QTc prolongation risk: Terbutaline significantly increases QTc interval (from 395ms to 449ms in one study) 7
  • Electrolyte disturbances: Causes hypokalemia and hypomagnesemia through intracellular shifting 2, 7

Monitoring Requirements:

If terbutaline is used, monitor closely for:

  • Heart rate and blood pressure response
  • ECG changes (QTc interval, ST segments, T-wave morphology)
  • Serum potassium and magnesium levels
  • Signs of myocardial ischemia (chest pain, new ST changes)
  • Tachyarrhythmias

The Early Repolarization Context

Early repolarization with upward-sloping ST segments is generally a benign finding in young, healthy individuals. However, the presence of sinus bradycardia requiring treatment suggests this is NOT a benign athletic heart scenario. You must determine:

  • Is there underlying structural heart disease?
  • Is there coronary artery disease risk?
  • What caused the bradycardia to become symptomatic?

Practical Algorithm

  1. Symptomatic sinus bradycardia identified → Check hemodynamics
  2. Hemodynamically stable → Evaluate reversible causes, no acute therapy needed
  3. Hemodynamically unstable → Start with atropine 0.5-1 mg IV (preferred)
  4. Atropine fails or contraindicated → Assess ischemic risk:
    • High ischemic risk: Consider temporary pacing, NOT beta-agonists
    • Low ischemic risk: May consider terbutaline or other beta-agonists
  5. If terbutaline used: Start 2.5 mg PO q6-8h, monitor electrolytes and ECG closely

Common Pitfalls to Avoid

  • Don't use terbutaline as first-line: Atropine is safer and preferred 1
  • Don't ignore ischemic risk: The guidelines specifically limit beta-agonist use to low-ischemia patients 1
  • Don't forget electrolyte monitoring: Terbutaline-induced hypokalemia can worsen arrhythmias 2, 7
  • Don't overlook medication causes: Many antiarrhythmics and other drugs cause bradycardia 1

Bottom line: Terbutaline is not contraindicated by early repolarization per se, but requires careful assessment of ischemic risk, symptom severity, and failure of safer alternatives before use.

References

3
Research

Cardiovascular and metabolic effects of terbutaline.

Journal of clinical and hospital pharmacy, 1982

6
Research

Terbutaline for chronotropic support in heart transplantation.

The Annals of pharmacotherapy, 2004

Related Questions

In an adult with isolated sinus bradycardia and no contraindications, how can the heart rate be increased without raising blood pressure?
How should I diagnose and manage a patient with hypotension (BP 103/60 mmHg), sinus bradycardia (heart rate 47‑53 bpm) and a prolonged QT interval on a 12‑lead ECG?
In a 75-year-old man with hyperlipidemia, thyroid disease, benign prostatic hyperplasia, pre‑diabetes, and bradycardia who presents with orthostatic hypotension and dizziness and has sinus bradycardia on Holter monitoring, what is the next step in management?
What is the appropriate outpatient evaluation and management plan for a 32-year-old woman with no past medical history who experiences episodes of sinus bradycardia with heart rates in the 30s?
What is the appropriate management of marked sinus bradycardia in a patient with a prior stroke?
What pharmacologic treatments are recommended for a 12‑year‑old girl with secondary amenorrhea?
What are the recommended antibiotic regimens for open fractures, including dosing, adjustments for renal impairment, MRSA risk, and β‑lactam allergy?
Is sinus bradycardia with early repolarization and an upward‑sloping ST segment considered high risk for malignant arrhythmia?
Is it safe to add tadalafil 5 mg (Tadaflo) for erectile dysfunction to my current regimen of levothyroxine 37.5 µg, liothyronine 5 µg, carvedilol 6.25 mg, and telmisartan 20 mg, or should any doses be adjusted given my blood pressure?
If stool culture shows Salmonella that is susceptible to ceftriaxone, can ceftriaxone be used as monotherapy?
What is the treatment for heart failure with reduced ejection fraction in an 11‑month‑old infant?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.